Real-time · AI · Cross-signal

Salipro Biotech AB just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Salipro Biotech AB, plus every launch, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your plan Request a demo

▶

Watch the 2-minute tour · with sound

Salipro Biotech granted patents in Australia and Singapore for its Salipro® platform technology aimed at drug discovery.

Dec 05, 2024•over 1 year ago

SwedenBiotechnologyPharmaceutical

Product Description

Salipro Biotech has announced the issuance of patents in Singapore and Australia for its Salipro® platform technology, which is crucial for isolating and purifying native membrane proteins, impacting drug discovery initiatives.

Company Information

Company

Salipro Biotech AB

Location

Sweden

About

Salipro Biotech AB is a privately held biotechnology company focused on unlocking challenging drug targets for the development of next-generation therapeutics. They specialize in the stabilization of membrane proteins through their proprietary Salipro® technology, which is critical for drug discovery programs. Salipro Biotech collaborates with leading pharmaceutical companies to enhance drug development processes. The company is committed to addressing unmet medical needs with innovative solutions.

Predictive Intelligence

Strategic

ML-powered predictions for Salipro Biotech AB's next move

Learn about Strategic plan

Product Launch Insights

Based on market data

Market expansion signals

New product launches often coincide with market expansion initiatives

Related People

Suggested for you

Choose your plan to view verified contacts